Cargando…
New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a specific subtype of breast cancer lacking hormone receptor expression and HER2 gene amplification. TNBC represents a heterogeneous subtype of breast cancer, characterized by poor prognosis, high invasiveness, high metastatic potential, and a tendency to rela...
Autores principales: | El Hejjioui, Brahim, Lamrabet, Salma, Amrani Joutei, Sarah, Senhaji, Nadia, Bouhafa, Touria, Malhouf, Moulay Abdelilah, Bennis, Sanae, Bouguenouch, Laila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252475/ https://www.ncbi.nlm.nih.gov/pubmed/37296801 http://dx.doi.org/10.3390/diagnostics13111949 |
Ejemplares similares
-
Clinical Evidence of Circulating Tumor DNA Application in Aggressive Breast Cancer
por: El Hejjioui, Brahim, et al.
Publicado: (2023) -
Molecular and Circulating Biomarkers in Patients with Glioblastoma
por: Senhaji, Nadia, et al.
Publicado: (2022) -
Clinicopathological, therapeutic and prognostic features of the triple-negative tumors in moroccan breast cancer patients (experience of Hassan II university hospital in Fez)
por: Akasbi, Yousra, et al.
Publicado: (2011) -
EWSR1 Rearrangement and CD99 Expression as Diagnostic Biomarkers for Ewing/PNET Sarcomas in a Moroccan Population
por: Louati, Sara, et al.
Publicado: (2018) -
Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review
por: Alami, Zenab, et al.
Publicado: (2022)